Published in J Neurosci on January 19, 2011
Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma (2012) 1.41
Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia. Cold Spring Harb Perspect Biol (2014) 1.36
Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. J Neurosci (2013) 1.31
Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity (2016) 1.22
Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation (2012) 1.20
Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol (2011) 1.11
Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease. Front Immunol (2012) 1.07
Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury. Mol Brain (2013) 1.05
Protease regulation: the Yin and Yang of neural development and disease. Neuron (2011) 1.00
Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury. Exp Neurol (2011) 0.99
Expressing Constitutively Active Rheb in Adult Neurons after a Complete Spinal Cord Injury Enhances Axonal Regeneration beyond a Chondroitinase-Treated Glial Scar. J Neurosci (2015) 0.99
Function of microglia and macrophages in secondary damage after spinal cord injury. Neural Regen Res (2014) 0.94
Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis. PLoS One (2012) 0.93
Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells. Front Neurosci (2013) 0.91
Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J Neuroinflammation (2011) 0.88
Long- and short-term intravital imaging reveals differential spatiotemporal recruitment and function of myelomonocytic cells after spinal cord injury. J Physiol (2013) 0.86
Comparison of phenotypic markers and neural differentiation potential of multipotent adult progenitor cells and mesenchymal stem cells. World J Stem Cells (2013) 0.86
Permissive Schwann cell graft/spinal cord interfaces for axon regeneration. Cell Transplant (2013) 0.85
Intrathecal Transplantation of Autologous Adherent Bone Marrow Cells Induces Functional Neurological Recovery in a Canine Model of Spinal Cord Injury. Cell Transplant (2014) 0.84
Age-dependent changes in the proteome following complete spinal cord transection in a postnatal South American opossum (Monodelphis domestica). PLoS One (2011) 0.84
Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment. Neuroscience (2012) 0.84
Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury. Sci Rep (2015) 0.83
Human mesenchymal cells from adipose tissue deposit laminin and promote regeneration of injured spinal cord in rats. PLoS One (2014) 0.83
Cell-based therapy for neural disorders--anticipating challenges. Neurotherapeutics (2011) 0.83
Dependence of regenerated sensory axons on continuous neurotrophin-3 delivery. J Neurosci (2012) 0.81
Recent advances in the pharmacologic treatment of spinal cord injury. Metab Brain Dis (2014) 0.79
Potential of olfactory ensheathing cells from different sources for spinal cord repair. PLoS One (2013) 0.78
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis. Anat Cell Biol (2012) 0.78
Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury. Stem Cell Res Ther (2015) 0.78
Anti-Inflammatory Mechanism of Neural Stem Cell Transplantation in Spinal Cord Injury. Int J Mol Sci (2016) 0.77
NG2+ progenitors derived from embryonic stem cells penetrate glial scar and promote axonal outgrowth into white matter after spinal cord injury. Stem Cells Transl Med (2015) 0.76
Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice. Inflammation (2016) 0.75
Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain. J Neuroinflammation (2015) 0.75
miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair. J Neurosci (2016) 0.75
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells. Stem Cell Res Ther (2015) 0.75
Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells. Stem Cells Int (2017) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci (2007) 11.24
Regeneration beyond the glial scar. Nat Rev Neurosci (2004) 11.00
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93
Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science (2008) 6.86
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci (2005) 5.66
Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron (1999) 4.13
Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science (1981) 3.94
In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med (2005) 3.88
Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci (2005) 3.74
cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med (2004) 3.65
Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci (2006) 3.21
Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol (2002) 2.72
Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol (2002) 2.71
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A (2008) 2.70
Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci (2005) 2.61
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant (2007) 2.47
Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci (1999) 2.43
Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury. Nat Neurosci (2009) 2.42
Macrophage-derived factors stimulate optic nerve regeneration. J Neurosci (2003) 2.26
Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci (2002) 2.21
Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci (2008) 2.20
Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci (2004) 2.10
Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci (2001) 2.03
NG2 glial cells provide a favorable substrate for growing axons. J Neurosci (2006) 1.99
Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci (2009) 1.81
Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci (2009) 1.80
Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery (2006) 1.78
Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron (2009) 1.76
Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J Neurosci (2007) 1.63
Stem cells for spinal cord repair. Cell Stem Cell (2008) 1.63
Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci (2010) 1.61
Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci (2010) 1.59
Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci (2003) 1.52
Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood (2006) 1.43
Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke (2005) 1.42
Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma (2006) 1.41
BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci (2009) 1.40
The evolving roles of axonally synthesized proteins in regeneration. Curr Opin Neurobiol (2006) 1.34
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab (2008) 1.22
Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab (2007) 1.21
Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J Cereb Blood Flow Metab (2010) 1.19
Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor Neurol Neurosci (2009) 1.15
Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy (2007) 1.07
Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus (2008) 1.06
Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cell Immunol (2008) 0.98
Development of adult pluripotent stem cell therapies for ischemic injury and disease. Expert Opin Biol Ther (2007) 0.97
Retrograde axonal degeneration "dieback" in the corticospinal tract after transection injury of the rat spinal cord: a confocal microscopy study. J Neurotrauma (2007) 0.94
Therapeutic pathways of adult stem cell repair. Crit Rev Oncol Hematol (2007) 0.82
Adult stem cell therapies for neurological disorders: benefits beyond neuronal replacement? J Neurosci Res (2009) 0.81
Stem cell biology and its therapeutic applications in the setting of spinal cord injury. Neurosurg Focus (2008) 0.81
Functional regeneration of respiratory pathways after spinal cord injury. Nature (2011) 4.07
CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol (2007) 4.00
Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci (2006) 3.21
Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron (2003) 3.19
PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science (2009) 2.84
The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol (2007) 2.77
Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury. J Neurosci (2013) 2.43
Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci (2008) 2.20
Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci (2004) 2.10
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci (2005) 2.07
Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J Neurosci (2006) 2.00
Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem (2005) 1.86
Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci (2009) 1.81
Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circ Res (2011) 1.77
Light-induced rescue of breathing after spinal cord injury. J Neurosci (2008) 1.68
VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med (Berl) (2008) 1.67
Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci (2010) 1.61
Astrocyte-associated fibronectin is critical for axonal regeneration in adult white matter. J Neurosci (2004) 1.54
Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J Neurosci (2011) 1.52
Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol (2010) 1.42
Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A (2006) 1.37
Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol (2007) 1.35
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab (2008) 1.22
A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J Neurosci (2004) 1.21
Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood (2012) 1.20
Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. J Neurosci (2013) 1.20
Identification of novel and improved antimitotic agents derived from noscapine. J Med Chem (2005) 1.20
The SONB(NUP98) nucleoporin interacts with the NIMA kinase in Aspergillus nidulans. Genetics (2003) 1.17
Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population. J Neuroinflammation (2012) 1.15
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 1.10
Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther (2011) 1.09
The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci (2005) 1.08
Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. J Stem Cells (2009) 1.06
Human artificial chromosomes with alpha satellite-based de novo centromeres show increased frequency of nondisjunction and anaphase lag. Mol Cell Biol (2003) 1.04
Precursors of neurons, neuroglia, and ependymal cells in the CNS: what are they? Where are they from? How do they get where they are going? Glia (2003) 1.04
The extracellular matrix in axon regeneration. Prog Brain Res (2002) 1.02
Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia. Circulation (2013) 1.01
The unusual response of serotonergic neurons after CNS Injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar. J Neurosci (2011) 1.00
Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC. Dev Neurobiol (2010) 0.99
Activin acutely sensitizes dorsal root ganglion neurons and induces hyperalgesia via PKC-mediated potentiation of transient receptor potential vanilloid I. J Neurosci (2007) 0.99
The critical role of basement membrane-independent laminin gamma 1 chain during axon regeneration in the CNS. J Neurosci (2002) 0.98
The Grb2/PLD2 interaction is essential for lipase activity, intracellular localization and signaling in response to EGF. J Mol Biol (2007) 0.97
Development of adult pluripotent stem cell therapies for ischemic injury and disease. Expert Opin Biol Ther (2007) 0.97
Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. Stem Cells Transl Med (2013) 0.95
A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke. Int J Stroke (2013) 0.95
Electrical stimulation of intact peripheral sensory axons in rats promotes outgrowth of their central projections. Exp Neurol (2007) 0.94
Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough? Exp Neurol (2013) 0.94
Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity. J Immunol (2013) 0.94
Serotonergic neurons migrate radially through the neuroepithelium by dynamin-mediated somal translocation. J Neurosci (2010) 0.94
Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant (2009) 0.92
Treatments to restore respiratory function after spinal cord injury and their implications for regeneration, plasticity and adaptation. Exp Neurol (2011) 0.92
A point mutation in the Aspergillus nidulans sonBNup98 nuclear pore complex gene causes conditional DNA damage sensitivity. Genetics (2006) 0.91
Development of a surrogate angiogenic potency assay for clinical-grade stem cell production. Cytotherapy (2012) 0.90
Multipotent embryonic spinal cord stem cells expanded by endothelial factors and Shh/RA promote functional recovery after spinal cord injury. Exp Neurol (2007) 0.89
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Immunotherapy (2012) 0.88
A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI. Exp Neurol (2010) 0.88
Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus. Rev Neurosci (2006) 0.87
Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis. J Nat Prod (2002) 0.84
Shedding light on restoring respiratory function after spinal cord injury. Front Mol Neurosci (2009) 0.84
The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice. Biomaterials (2012) 0.83
Discovery of S-phase arresting agents derived from noscapine. J Med Chem (2005) 0.83
Fibronectin inhibits chronic pain development after spinal cord injury. J Neurotrauma (2012) 0.83
Therapeutic pathways of adult stem cell repair. Crit Rev Oncol Hematol (2007) 0.82
Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction. Cell Transplant (2011) 0.82
An anti-HIV-1 gp120 antibody expressed as an endocytotic transmembrane protein mediates internalization of HIV-1. Virology (2003) 0.81
Keratan sulfate proteoglycan phosphacan regulates mossy fiber outgrowth and regeneration. J Neurosci (2004) 0.80
Extravascular CX3CR1+ cells extend intravascular dendritic processes into intact central nervous system vessel lumen. Microsc Microanal (2013) 0.79
Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation. Cancer Res (2003) 0.79
Adult adherent stromal cells in the management of graft-versus-host disease. Expert Opin Biol Ther (2014) 0.78
Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I). Cell Transplant (2012) 0.78
Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis. Stem Cells Transl Med (2013) 0.77
Oncomodulin affords limited regeneration to injured sensory axons in vitro and in vivo. Exp Neurol (2011) 0.77
Restoration of retinal development in Vsx2 deficient mice by reduction of Gdf11 levels. Adv Exp Med Biol (2012) 0.77
A small inhibitor of the interaction between Bax and Bcl-X(L) can synergize with methylprednisolone to induce apoptosis in Bcl-X(L)-overexpressing breast-cancer cells. J Cancer Res Clin Oncol (2003) 0.76
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists. Bioorg Med Chem Lett (2005) 0.75
Discovery of 1,2,3-Triazole Derivatives for Multimodality PET/CT/Cryoimaging of Myelination in the Central Nervous System. J Med Chem (2017) 0.75
831 Prelesion but Not Postlesion Inflammation Plus Proteoglycan Degradation Results in Functional Regeneration. Neurosurgery (2005) 0.75
3-Indolyl sultams as selective CRTh2 antagonists. Bioorg Med Chem Lett (2010) 0.75